Cross‐Binding Between Plasmodium falciparum CTL Epitopes and HLA Class I Molecules

References

• Aidoo M., Lalvani A., Allsopp C. E.M., Plebanski M., Meisner S. J., Krausa P., Browning M., Morris‐Jones S., Gotch F., Fidock D. A., Takiguchi M., Robson K. J.H., Greenwood B. M., Druilhe P., Whittle H. C., Hill A. V.S. Identification of conserved antigenic components for a cytotoxic T lymphocyte‐inducing vaccine against malaria. Lancet 1995; 345: 1003–1007
   PubMed Web of Science ®Google Scholar
• Bertoletti A., Southwood S., Chesnut R., Sette A., Falco M., Ferrara G. B., Penna A., Boni C., Fiaccadori F., Ferrari C. Molecular features of the hepatitis B virus nucleocapsid T‐cell epitope 18–27: interaction with HLA an T‐cell receptor. Hepatology 1997; 26(4)1027–1034
   Google Scholar
• Bertoni R., Sidney J., Fowler P., Chesnut R. W., Chisari F. V., Sette A. Human histocompatibility leukocyte antigen‐binding supermotifs predict broadly cross‐reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 1997; 10(3)503–513
   Google Scholar
• Del V. M., Schlicht H. J., Ruppert T., Reddehase M. J., Koszinowski U. H. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 1991; 66(6)1145–1153
   Google Scholar
• Doolan D. L., Hoffman S. L., Southwood S., Wentworth P. A., Sidney J., Chesnut R. W., Keogh E., Appella E., Nutman T. B., Lal A. A., Gordon D. M., Oloo A., Sette A. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA‐A and HLA‐B supertype alleles. Immunity 1997; 7(1)97–112
   PubMedGoogle Scholar
• Feltkamp M. C., Vierboom M. P., Kast W. M., Melief C. J. Efficient MHC class I‐peptide binding is required but does not ensure MHC class I‐restricted immunogenicity. Mol. Immunol. 1994; 31: 1391–1398
   PubMed Web of Science ®Google Scholar
• Fleischhauer K., Tanzarella S., Wallny H. J., Bordignon C., Traversari C. Multiple HLA‐A alleles can present an immunodominant peptide of the human melanoma antigen Melan‐A/MART‐1 to a peptide‐specific HLA‐A*0201 cytotoxic T cell line. J. Immunol. 1996; 157(2)787–797
   Google Scholar
• Hill A. V., Elvin J., Willis A., Aidoo M., Allsopp C. E.M., Gotch F. M., Gao X. M., Takiguchi M., Greenwood B. M., Townsend A. R.M., McMichael A. J., Whittle H. C. Molecular analysis of the association of HLA‐B53 and resistance to severe malaria. Nature 1992; 360: 434–439
   PubMed Web of Science ®Google Scholar
• Kawashima I., Hudson S. J., Tsai V., Southwood S., Takesako K., Appella E., Sette A., Celis E. The multi‐epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor‐associated antigens expressed on solid epithelial tumors. Hum. Immunol. 1998; 59(1)1–14
   PubMed Web of Science ®Google Scholar
• Khanna R., Burrows S. R., Nicholls J., Poulsen L. M. Identification of cytotoxic T cell epitopes within Epstein‐Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): Evidence for HLA‐A2 supertype‐restricted immune recognition of EBV‐infected cells by LMP1‐specific cytotoxic T lymphocytes. Eur. J. Immunol. 1998; 28(2)451–458
   Google Scholar
• Kubo R. T., Sette A., Grey H. M., Appella E., Sakaguchi K., Zhu N. Z., Arnott D., Sherman N., Shabanowitz J., Michel H. Definition of specific peptide motifs for four major HLA‐A alleles. J. Immunol. 1994; 152: 3913–3924
   PubMed Web of Science ®Google Scholar
• Ojcius D. M., Abastado J. P., Casrouge A., Mottez E., Cabanie L., Kourilsky P. Dissociation of the peptide‐MHC class I complex limits the binding rate of exogenous peptide. J. Immunol. 1993; 151(11)6020–6206
   Google Scholar
• Otten G. R., Bikoff E., Ribaudo R. K., Kozlowski S., Margulies D. H., Germain R. N. Peptide and β2‐microglobulin regulation of cell surface MHC class I conformation and expression. J. Immunol. 1992; 148(12)3723–3732
   Google Scholar
• Perlman P., Miller L. Fogarty/WHO International Conference on cellular mechanisms in malaria immunity. Immunol. Lett. 1990; 25(1–3)1–283
   Google Scholar
• Sidney J., Grey H., Southwood S., Celis E., Wentworth P. A., Guercio M. F.D., Kubo R. T., Chesnut R. W., Sette A. Definition of an HLA‐A3 like supermotif demonstrates the overlapping peptide‐binding repertoires of common HLA molecules. Hum. Immunol. 1996a; 45: 79–93
   PubMed Web of Science ®Google Scholar
• Sidney J., Gray H. M., Kubo R. T., Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 1996b; 17(6)261–266
   PubMedGoogle Scholar
• Tang Y., Wang H. Construction and immunogenicity prediction of Plasmodium falciparum CTL epitope minigene vaccine. Sci. China (Series C). 2001; 31(1)59–65
   Google Scholar
• Threlkeld S. C., Wentworth P. A., Kalams S. A., Wilkes B. M., Ruhl D. J., Keogh E., Sidney J., Southwood S., Walker B. D., Sette A. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3‐like superfamily: Implications for vaccine development. J. Immunol. 1997; 159(4)1648–1657
   Google Scholar
• Van D. B.S.H., Visseren M. J., Brandt R. M., Kast W. M., Melief C. J. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC‐peptide complex stability. J. Immunol. 1996; 156(9)3308–3314
   Google Scholar